Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Up 0.4%
Fri, 9 Aug 13:29

ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Up 0.4%Image source: CreativaImages/www.istockphoto.com

ALEMBIC PHARMA share price has plunged 5% and is presently trading at Rs 1,152.3.

Meanwhile, the BSE HEALTHCARE index is at 41,098.6 (up 0.4%).

Among the top losers in the BSE HEALTHCARE index today are FDC (down 1.8%) and Aurobindo Pharma (down 1.3%).

Lupin (up 3.0%) and ERIS LIFESCIENCES (up 2.3%) are among the top gainers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 793.6 to Rs 1,152.3, registering a gain of Rs 358.8 (up 45.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,098.6, registering a gain of 45.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 115.0%), GSK Pharma (up 107.4%) and GRANULES INDIA (up 106.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,712.1 (up 1.0%).

The top gainers among the BSE Sensex today are Tata Motors (up 2.9%) and JSW Steel (up 2.8%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,361.3 (up 1.0%). Eicher Motor and Grasim Industries are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,712.1, registering a gain of 13,758.6 points (up 20.9%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 11.3% YoY to Rs 1,342 million for the quarter ended June 2024, compared to a profit of Rs 1,206 million a year ago. Net sales rose 5.1% to Rs 15,617 million during the period as against Rs 14,862 million in April-June 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 35.9.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Up 0.4%". Click here!